IMMUNOONE

Serial Number 79361819
Registration 7204166
700

Registration Progress

Application Filed
Dec 20, 2022
Under Examination
Approved for Publication
Aug 15, 2023
Published for Opposition
Aug 15, 2023
Registered
Oct 31, 2023

Trademark Image

IMMUNOONE

Basic Information

Serial Number
79361819
Registration Number
7204166
Filing Date
December 20, 2022
Registration Date
October 31, 2023
Published for Opposition
August 15, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 31, 2023
Registration
Registered
Classes
005 042 044

Rights Holder

OncoOne Research & Development GmbH

27
Address
Höhenstraße 19/2
A-3400 Klosterneuburg
AT

Ownership History

OncoOne Research & Development GmbH

Original Applicant
99
AT

OncoOne Research & Development GmbH

New Owner Before Publication #1
27
AT

OncoOne Research & Development GmbH

Owner at Publication
27
AT

OncoOne Research & Development GmbH

Original Registrant
27
AT

Legal Representation

Attorney
Michael Fedrick

USPTO Deadlines

Next Deadline
1405 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20231031)
Due Date
October 31, 2029
Grace Period Ends
April 30, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Nov 21, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Feb 27, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 6, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Feb 6, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jan 31, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Oct 31, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 31, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 15, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 15, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 26, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 11, 2023 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Jun 27, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 26, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 26, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 26, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 26, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 15, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 14, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 14, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 31, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
May 5, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 5, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 17, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 16, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 14, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 10, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 6, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 3, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical, medical and veterinary preparations for the treatment of hyperproliferative and inflammatory diseases; pharmaceutical, medical and veterinary preparations comprising antibodies, antibody derivatives, and antigen binding fragments for the treatment of hyperproliferative and inflammatory diseases
Class 042
Scientific and technological services and research, namely, scientific research, analysis and testing in the field of diseases using antibodies, antibody derivatives and antigen binding fragments; scientific and technological services and research in the nature of scientific research for the treatment and prevention of diseases using antibodies, antibody derivatives, and antigen binding fragments; analytical and research services; analytical scientific research and medical and scientific research services, namely, descriptive, diagnostic, predictive and prescriptive analytics for the treatment and prevention of disease using antibodies, antibody derivatives, and antigen binding fragments; pharmaceutical and biotechnological research and development; biotechnological research services
Class 044
Medical and veterinary services, namely, services for the treatment and prevention of diseases using antibodies, antibody derivatives, and antigen binding fragments

Classification

International Classes
005 042 044